John E. Harris

Dr. John E. Harris is a Professor and Chair in the Department of Dermatology at UMass Chan Medical School, where he founded the Vitiligo Clinic and Research Center and the Autoimmune Therapeutics Institute. He integrates basic, translational, and clinical research to advance vitiligo treatments and understand autoimmune mechanisms.

• Co-founder and Board Member, Vitiligo Working Group
• Board Member, New England Dermatology Society
• Scientific Advisory Board, Vitiligo Research Foundation
• Advisor to pharmaceutical companies: AbbVie, Combe Inc, Genzyme/Sanofi, Pfizer

His research interests span vitiligo pathogenesis, JAK-STAT signaling inhibition, T cell immunology, and translational therapies. Recent work focuses on siRNA delivery systems, mouse models, mental health burden, and immune monitoring techniques. He serves as an ad hoc reviewer for NIH, Dermatology Foundation, and journals like Science Translational Medicine.

Dr. Harris' peer-reviewed publications highlight targeted immunomodulation, biomarker discovery, and equity in drug development. His grants include support from NIH, Dermatology Foundation, Kawaja Vitiligo Initiative, and Vitiligo Research Foundation.